We serve Chemical Name:1H-Imidazo[4,5-f]quinoline(8CI,9CI) CAS:233-55-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![1H-Imidazo[4,5-f]quinoline(8CI,9CI)](https://a.dearchem.com/CAS2/233-55-6.png)
Chemical Name:1H-Imidazo[4,5-f]quinoline(8CI,9CI)
CAS.NO:233-55-6
Synonyms:7-Imidazo<4,5-b>pyridine carboxylic acid;1H-Imidazo<4,5-f>quinoline;Imidazo<4,5-f>chinolin
Molecular Formula:C10H7N3
Molecular Weight:169.18300
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:489.8ºC at 760mmHg
Density:1.381g/cm3
Index of Refraction:1.804
PSA:41.57000
Exact Mass:169.06400
LogP:2.11110
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 7-Imidazo< chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,chinolin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,quinoline Use and application,pyridine carboxylic acid technical grade,usp/ep/jp grade.
Related News: Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies. 1H-Imidazo[4,5-f]quinoline(8CI,9CI) manufacturer Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies. 1H-Imidazo[4,5-f]quinoline(8CI,9CI) supplier This is very visible in herbal medicines in which the API is frequently a combination of several mixtures and/or substances which when used together cause pharmacological activity on the body. 1H-Imidazo[4,5-f]quinoline(8CI,9CI) vendor Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies. 1H-Imidazo[4,5-f]quinoline(8CI,9CI) factory Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.
